Invesco Nasdaq Future Gen 200 ETF Rating $43.55 -0.56 (-1.27%) As of 07/2/2026 02:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsTrendsBuy This Stock Invesco Nasdaq Future Gen 200 ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.QQQS Aggregate RatingHold 2.33Holdings in QQQS have an aggregate rating of Hold based on 177 analyst ratings issued in the past year covering 24 companies (15.9% of the portfolio).QQQS Aggregate Price Target$43.55High Prediction$43.55Average Prediction$43.55Low Prediction$43.55Holdings in QQQS have an aggregate price target of $43.55 and a range of $43.55 to $43.55 covering 24 companies (15.9% of the portfolio).QQQS Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold13 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by Invesco Nasdaq Future Gen 200 ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 24 QQQS Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings0.90%NWLNewell Brands$5.832.5664 of 5 stars2.10$4.94 -15.2%10News Coverage0.86%ARQQArqit Quantum$23.511.9009 of 5 stars2.00$60.00 155.2%2News CoverageNegative NewsInsider TradeGap Up0.73%CLPTClearPoint Neuro$18.722.3337 of 5 stars2.33$23.00 22.9%3News CoveragePositive NewsInsider Trade0.71%MYGNMyriad Genetics$5.991.7096 of 5 stars2.00$6.50 8.5%6News Coverage0.69%QMCOQuantum$10.163.8493 of 5 stars2.25$17.67 73.9%4Trending NewsAnalyst RevisionGap Up0.68%OCCOptical Cable$16.000.4148 of 5 stars1.001Analyst Upgrade0.66%PGENPrecigen$5.642.9303 of 5 stars2.33$12.50 121.6%6News CoverageInsider TradeGap Down0.66%ENTGEntegris$146.663.7423 of 5 stars2.55$156.56 6.7%11Positive NewsAnalyst Forecast0.66%LGNDLigand Pharmaceuticals$319.552.1979 of 5 stars2.88$257.71 -19.4%80.66%TLSITriSalus Life Sciences$4.693.5276 of 5 stars2.25$7.50 59.9%4Positive NewsGap Down0.65%TXG10x Genomics$39.011.7888 of 5 stars2.20$25.92 -33.6%15Analyst Forecast0.64%XNCRXencor$15.001.928 of 5 stars2.40$24.50 63.3%10Positive News0.64%AGIOAgios Pharmaceuticals$37.581.6685 of 5 stars2.45$40.89 8.8%11Positive NewsAnalyst Revision0.64%QTRXQuanterix$4.331.268 of 5 stars1.67$4.00 -7.6%30.63%RIGLRigel Pharmaceuticals$38.723.8728 of 5 stars2.33$54.50 40.8%60.62%SIBNSiBone$17.111.8128 of 5 stars2.71$23.00 34.4%70.62%ANGOAngioDynamics$13.093.0143 of 5 stars2.67$18.67 42.6%60.62%MLKNMillerKnoll$21.424.0731 of 5 stars2.003Analyst DowngradeGap Up0.61%SIMOSilicon Motion Technology$300.714.6981 of 5 stars3.00$246.43 -18.1%10Analyst DowngradeGap Up0.61%RNACCartesian Therapeutics$10.593.8319 of 5 stars2.43$32.60 207.8%7News CoverageAnalyst Downgrade0.59%KIDSOrthoPediatrics$19.953.4403 of 5 stars2.73$24.44 22.5%11Gap Down0.59%ATECAlphatec$8.922.573 of 5 stars2.75$18.58 108.3%120.59%AVNWAviat Networks$21.174.5831 of 5 stars2.60$33.14 56.6%10Positive NewsAnalyst ForecastAnalyst RevisionGap Up0.59%ZVRAZevra Therapeutics$13.984.1305 of 5 stars2.82$29.29 109.5%11 This page (NASDAQ:QQQS) was last updated on 7/5/2026 by MarketBeat.com Staff. From Our PartnersTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredBetter than SpaceX? Grab this ticker instead.Larry Benedict generated $274 million for his clients by finding the trades most investors missed. Now he says...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Nasdaq Future Gen 200 ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Nasdaq Future Gen 200 ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
